Efficacy and Safety of E.Coli Nissle 1917 in Patients With Mild (Stage 1-2) or Minimal Hepatic Encephalopathy

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
The purpose of study to assess the short-term efficacy and safety of probiotic E.coli Nissle 1917 strain comparing to lactulose and rifaximin in patients with mild (Stage 1-2) or minimal hepatic encephalopathy
Epistemonikos ID: 64015e70d4cd75373cfd3f91e9fbb604882e6aad
First added on: May 08, 2024